U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07580027) titled 'Preoperative, Adaptive Radiotherapy Concomitant to Chemotherapy for Rectal Adenocarcinoma (Adaptive Rectal Cancer Trial 02)' on March 20.
Brief Summary: The aim of this clinical study is to increase the rate of pathological responses up to 70% by means of improved patient selection operated by a radiobiological index called ERI\_TCP and by an increase in the dose of radiotherapy in the final concomitant boost of preoperative radiochemotherapy treatment for rectal adenocarcinoma.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Locally Advanced Rectal Carcinoma
Intervention:
RADIATION: Preoperative, adaptive radi...